Annotation Detail for DIAPH2

Basic Information
Top
| Pathway ID | Pathway Name |
|---|
| hsa04810 | Regulation of actin cytoskeleton |
| Pathway ID | Pathway Name |
|---|
| P00016 | Cytoskeletal regulation by Rho GTPase |
| Desease Name |
|---|
| Premature ovarian failure |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of DIAPH2 protein | affects expression | 20106945
|
| D001104 |
Arbutin |
Arbutin results in decreased expression of DIAPH2 mRNA | decreases expression | 17103032
|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of DIAPH2 mRNA | decreases expression | 20106945 20064835
|
| D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of DIAPH2 mRNA | affects expression | 20382639
|
| C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of DIAPH2 mRNA | affects expression | 17440010
|
| C024746 |
tobacco tar |
tobacco tar results in decreased expression of DIAPH2 mRNA | decreases expression | 19559774
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.04 | 20464547 20127859 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.82 | 6695378 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.49 | 19183758 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.00 | 20146248 17474063 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
1.98 | 12907637 21507988 12619106 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.12 | 20419170 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.78 | 20889678 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
tobacco tar |
7.78 | 19559774 |
| MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.57 | 20426865 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.57 | 16530937 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.80 | 20471113 |
| MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
6.27 | 17440010 |
| MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
4.89 | 18177683 15890375 9163691 2125692 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.89 | 20195826 21137059 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
2.92 | 8603461 |
| MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.49 | 14755239 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.49 | 6695378 17053015 18569708 18520028 20135361 20869020 20464547 20064080 18816296 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.43 | 16381670 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.30 | 11141357 |
| MESH:D016649 |
Primary Ovarian Insufficiency |
marker/mechanism |
|
| |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.92 | 17292933 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.49 | 10029692 19755658 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.28 | 17053015 |
| Pathway ID |
Pathway Name |
|---|
| KEGG:04810 |
Regulation of actin cytoskeleton |